193 related articles for article (PubMed ID: 9308730)
21. Association between expression of sialosyl-Tn antigen and intestinalization of gastric carcinomas.
Kushima R; Jancic S; Hattori T
Int J Cancer; 1993 Dec; 55(6):904-8. PubMed ID: 8253526
[TBL] [Abstract][Full Text] [Related]
22. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
[TBL] [Abstract][Full Text] [Related]
24. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis.
Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Oncol Rep; 2001; 8(3):485-9. PubMed ID: 11295067
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
26. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features.
Wang RQ; Fang DC
J Clin Pathol; 2003 May; 56(5):378-84. PubMed ID: 12719460
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of mucin expression in gastric carcinoma.
Kocer B; Soran A; Kiyak G; Erdogan S; Eroglu A; Bozkurt B; Solak C; Cengiz O
Dig Dis Sci; 2004 Jun; 49(6):954-64. PubMed ID: 15309883
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
Kunze E; Krassenkova I; Fayyazi A
Histol Histopathol; 2008 May; 23(5):539-48. PubMed ID: 18283638
[TBL] [Abstract][Full Text] [Related]
29. Altered GalNAc-alpha-2,6-sialylation compartments for mucin-associated sialyl-Tn antigen in colorectal adenoma and adenocarcinoma.
Wang F; Goto M; Kim YS; Higashi M; Imai K; Sato E; Yonezawa S
J Histochem Cytochem; 2001 Dec; 49(12):1581-92. PubMed ID: 11724906
[TBL] [Abstract][Full Text] [Related]
30. Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases.
David L; Nesland JM; Clausen H; Carneiro F; Sobrinho-Simões M
APMIS Suppl; 1992; 27():162-72. PubMed ID: 1520525
[TBL] [Abstract][Full Text] [Related]
31. Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma.
Toki F; Takahashi A; Aihara R; Ogata K; Ando H; Ohno T; Mochiki E; Kuwano H
World J Gastroenterol; 2010 Jun; 16(22):2764-70. PubMed ID: 20533596
[TBL] [Abstract][Full Text] [Related]
32. Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas.
Terada T; Nakanuma Y
Am J Clin Pathol; 1996 May; 105(5):613-20. PubMed ID: 8623771
[TBL] [Abstract][Full Text] [Related]
33. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
[TBL] [Abstract][Full Text] [Related]
34. Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis.
Hartman DJ; Nikiforova MN; Chang DT; Chu E; Bahary N; Brand RE; Zureikat AH; Zeh HJ; Choudry H; Pai RK
Am J Surg Pathol; 2013 Jul; 37(7):969-77. PubMed ID: 23681075
[TBL] [Abstract][Full Text] [Related]
35. Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer.
Yamada T; Watanabe A; Yamada Y; Shino Y; Tanase M; Yamashita J; Miwa T; Nakano H
Cancer; 1995 Nov; 76(9):1529-36. PubMed ID: 8635053
[TBL] [Abstract][Full Text] [Related]
36. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
38. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation.
Cao Y; Schlag PM; Karsten U
Virchows Arch; 1997 Sep; 431(3):159-66. PubMed ID: 9334836
[TBL] [Abstract][Full Text] [Related]
39. Differences between gastric signet-ring cell carcinoma and poorly differentiated adenocarcinoma: A comparison of histopathologic features determined by mucin core protein and trefoil factor family peptide immunohistochemistry.
Fujimoto A; Ishikawa Y; Ishii T; Yamada A; Igarashi Y; Ohmoto Y; Kaise M
Pathol Int; 2017 Aug; 67(8):398-403. PubMed ID: 28691258
[TBL] [Abstract][Full Text] [Related]
40. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis.
Yamashita Y; Chung YS; Horie R; Kannagi R; Sowa M
J Natl Cancer Inst; 1995 Mar; 87(6):441-6. PubMed ID: 7532228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
